J. Khong , I. MacGregor , A. Burns , L. Simms , M. Farrar , M. Harries , S. Williams , G. Whitfield , S. Pan
{"title":"Patient and Public Involvement: Gathering Patient and Carer Insights to Inform Future Research into Permanent Radiation-Induced Alopecia (pRIA)","authors":"J. Khong , I. MacGregor , A. Burns , L. Simms , M. Farrar , M. Harries , S. Williams , G. Whitfield , S. Pan","doi":"10.1016/j.ijrobp.2024.11.033","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Radiation-induced alopecia has significant psychological sequelae. We aimed to understand aspects of pRIA important to patients and carers to inform future research.</div></div><div><h3>Methods</h3><div>A multidisciplinary team including clinical oncology, dermatology, paediatric nursing, youth cancer support, and PPI specialists was established. Separate face-to-face focus groups were conducted for (1) parents/guardians of children aged 0-16 years and (2) teenagers and young adults aged 16-30 years, currently receiving cranial proton therapy and at risk of pRIA. All potential participants were approached by telephone or in-person and provided with an age-appropriate participant information sheet. Discussions explored three hair loss topics: perception and impact; support; future research.</div></div><div><h3>Results</h3><div>Seven participants were invited to each group. Two declined and three were unable to attend due to travel constraints, resulting in six participants in Group 1 and three participants in Group 2.</div><div>All participants in both groups highlighted the importance of individualised risk assessment and recommended information on supportive care (wigs, caps) be consolidated and communicated via a pictorial leaflet or short videos. They also preferred virtual follow up for research and were willing to complete questionnaires and provide regular photographs to monitor interventions.</div><div>Parents/guardians expressed concerns about children undergoing punch biopsy or receiving unlicensed or investigational treatments (oral, topical, hair transplant). Parents/guardians do not want to travel significant distances for dermatology or research appointments.</div><div>In contrast, teenagers and young adults favoured pro-active involvement in research including scalp-cooling pre-treatment each day, use of unlicensed or investigational treatments to improve pRIA (preference for oral instead of topical) and would accept associated minimal side effects.</div></div><div><h3>Conclusion</h3><div>PPI provided valuable insight into acceptability and relevance of pRIA research. Clear differences in opinions between patient groups were identified that should be considered when designing future research.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"121 3","pages":"Page e8"},"PeriodicalIF":6.4000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0360301624036071","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
Radiation-induced alopecia has significant psychological sequelae. We aimed to understand aspects of pRIA important to patients and carers to inform future research.
Methods
A multidisciplinary team including clinical oncology, dermatology, paediatric nursing, youth cancer support, and PPI specialists was established. Separate face-to-face focus groups were conducted for (1) parents/guardians of children aged 0-16 years and (2) teenagers and young adults aged 16-30 years, currently receiving cranial proton therapy and at risk of pRIA. All potential participants were approached by telephone or in-person and provided with an age-appropriate participant information sheet. Discussions explored three hair loss topics: perception and impact; support; future research.
Results
Seven participants were invited to each group. Two declined and three were unable to attend due to travel constraints, resulting in six participants in Group 1 and three participants in Group 2.
All participants in both groups highlighted the importance of individualised risk assessment and recommended information on supportive care (wigs, caps) be consolidated and communicated via a pictorial leaflet or short videos. They also preferred virtual follow up for research and were willing to complete questionnaires and provide regular photographs to monitor interventions.
Parents/guardians expressed concerns about children undergoing punch biopsy or receiving unlicensed or investigational treatments (oral, topical, hair transplant). Parents/guardians do not want to travel significant distances for dermatology or research appointments.
In contrast, teenagers and young adults favoured pro-active involvement in research including scalp-cooling pre-treatment each day, use of unlicensed or investigational treatments to improve pRIA (preference for oral instead of topical) and would accept associated minimal side effects.
Conclusion
PPI provided valuable insight into acceptability and relevance of pRIA research. Clear differences in opinions between patient groups were identified that should be considered when designing future research.
期刊介绍:
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.